Robert retweeted
This is perhaps the best thing produced by the internet in recent history.
[📹 linda. buzz.official]
Robert retweeted
A 30 percent vitamin C solution dissolved in DMSO cleared 86 percent of basal cell skin cancer lesions within eight weeks in a clinical trial. In a randomized study published in Biomedicine & Pharmacotherapy, researchers tested a topical mix of high-concentration ascorbic acid and dimethyl sulfoxide, a solvent that helps substances penetrate deeply into the skin.
Applied twice daily for eight weeks, the combination produced complete clearance in 13 of 15 lesions (86.7 percent) among patients with low-risk basal cell carcinoma. This rate exceeded that of the standard topical treatment imiquimod, which cleared 8 of 14 lesions (57.1 percent). The vitamin C–DMSO formulation also caused fewer side effects and avoided the lasting skin hypopigmentation sometimes seen with conventional topical therapies.
Because basal cell carcinoma is the most common form of skin cancer worldwide, these early results suggest a possible low-cost, non-invasive option. Larger trials are still required before the approach can be adopted as standard care.
[Burke, B., & Bailie, J.-E. (2022). Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma. Biomedicine & Pharmacotherapy, 148, 112710. DOI: 10.1016/j.biopha.2022.112710]
Robert retweeted
all these people suddenly comparing zuck to Steve Jobs because he put an agent in a shiny hockey puck is hilarious
Robert retweeted
Kamala Harris just attempted to explain AI & social media algorithms
𝗪𝗔𝗥𝗡𝗜𝗡𝗚: You will lose brain cells
(It's worse than you think)
Robert retweeted
Many discounts across the entire AI stack at the moment. I don't think they'll last long though.
Among a few other names, I'm pretty excited for the next $CIFR blue diamond (buy signal).
The last one gave us a ~130% rally.
I'll make sure you don't miss the next one. 🫡
Robert retweeted
A few people asked over the weekend what the calls to slow the pace of frontier AI mean for the buildout. Some thoughts:
Even if models never improved from here, just rolling out what they can already do would take more compute than the world can build for years. The debate about how fast AI should be allowed to improve is a fair one to have. It's about future generations of models.
Existing demand is the part I think people are misreading. Anthropic CEO Dario Amodei said in May they'd planned for 10x growth and were running at an 80x pace in the first quarter, and that's why they've had trouble supplying compute. OpenAI president Greg Brockman said in July they'll be in a compute shortage no matter what, and are choosing which products to scale. Google says it's processing 7x the tokens it did a year ago. Hundreds of millions of people use these models today, and most of them use a small part of what the models can already do. And every time more compute comes online, usage steps up again: limits come off for people already using it, customers who were turned away get on, and new use cases show up that weren't in anyone's plan.
Now supply. The constraint is HBM, the memory that sits inside every major AI chip. Three companies make it and all three are sold out this year. A new memory plant takes years to build. TrendForce has HBM shipments growing 50-60% next year. NVIDIA, the biggest buyer of it, expects its revenue to grow about 70% next year and calls that outlook 'supply-constrained', noting its customers' forecasts point closer to 100%. On our own bottom-up work, the memory constraint lands in about the same place as NVIDIA's growth number.
Then the chips need a building with power connected, which takes longer again. Goldmans reckons only about half the US capacity scheduled over the next two years will actually be built on time.
The risk to demand continues to seem heavily weighted to the upside. The risk to supply continues to seem weighted toward less capacity getting built, not more.
Robert retweeted
This is perhaps the best thing produced by the internet in recent history.
[📹 linda. buzz.official]
Robert retweeted
Unitree shares have risen over 620% in its debut.
That's the humanoid category getting its first real public benchmark, and the market just told you what it's willing to pay.
Two ways to play it from here.
$INDI is the supplier. Confirmed design wins at Unitree, sole sourced per management, plus content at Agibot and Figure AI. As far as anyone can find, it's the only US-listed Western semiconductor supplier with disclosed content inside Unitree.
Management puts it around $100 of content per robot across vision and radar. It trades at a $900 million market cap while the customer it ships into priced at $9 billion and just opened at seven times that.
$CCXI is the pure play. Churchill Capital XI is the vehicle merging with Agility Robotics at a $2.5 billion pre money valuation, converting to $AGLT once it closes. That makes Agility the only US-listed pure-play humanoid company.
Agility has Digit deployed at Amazon, GXO, Toyota, and Schaeffler. Over $300 million in binding multi-year orders for Digit v5. Foxconn led the PIPE with Nvidia, SoftBank, and Sony on the cap table.
Unitree just set the number the market is willing to pay for a humanoid company. Agility is the American equivalent at a fraction of it.
The supplier and the pure play. Both priced against a benchmark that didn't exist yesterday.
Robert retweeted
If you watch Jaws backwards, it is a heartwarming story about a shark who gives arms and legs to people who need them.
Robert retweeted
The Odyssey was good but I forgot just how loud IMAX can be. Those boat and storm scenes are no joke, RIP my eardrums.
Robert retweeted
Odyssey was great as expected, lucky enough to see it in IMAX. One criticism though, it is needlessly fucking loud.






















